175 related articles for article (PubMed ID: 2543643)
1. Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1.
Lai PK; Li X; Volsky DJ
Int J Cancer; 1989 Jun; 43(6):1104-11. PubMed ID: 2543643
[TBL] [Abstract][Full Text] [Related]
2. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
3. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
5. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes.
Hironaka T; Nagasaki M; Morikawa S; Hirai K
J Virol Methods; 1993 Oct; 44(2-3):141-54. PubMed ID: 8263111
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and tumor promoters.
Eliasson L; Nilsson MT; Kallin B; Klein G
Princess Takamatsu Symp; 1983; 14():139-45. PubMed ID: 6097578
[TBL] [Abstract][Full Text] [Related]
7. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
Takimoto T; Umeda R; Ogura H; Hatano M
Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
[TBL] [Abstract][Full Text] [Related]
9. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
10. Morphological and phenotypical changes in EBV positive lymphoblastoid cells infected by HIV-1.
De Rossi A; Calabro ML; D'Andrea E; Panozzo M; Saggiori D; Mammano F; Roncella S; Ferrarini M; Chieco-Bianchi L
Leukemia; 1992; 6 Suppl 3():38S-40S. PubMed ID: 1318475
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL).
Uccini S; Monardo F; Vitolo D; Faggioni A; Gradilone A; Aglianó AM; Manzari V; Ruco LP; Baroni CD
Am J Clin Pathol; 1989 Dec; 92(6):729-35. PubMed ID: 2556016
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
Becker Y; Tabor E; Asher Y
Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
[TBL] [Abstract][Full Text] [Related]
15. Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells.
Sundar SK; Ablashi DV; Armstrong GR; Zipkin M; Faggioni A; Levine PH
Int J Cancer; 1981 Oct; 28(4):503-7. PubMed ID: 6273335
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease.
Tanner JE; Menezes J
Blood; 1994 Dec; 84(11):3956-64. PubMed ID: 7949151
[TBL] [Abstract][Full Text] [Related]
17. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells.
Kawanishi M; Ito Y
Cancer Lett; 1980 Dec; 11(2):129-32. PubMed ID: 6257378
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells.
Ito Y; Kawanishi M; Harayama T; Takabayashi S
Cancer Lett; 1981 Apr; 12(3):175-80. PubMed ID: 6266651
[TBL] [Abstract][Full Text] [Related]
19. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
Moar MH; Klein G
Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
[TBL] [Abstract][Full Text] [Related]
20. The biological activity of hydrogen peroxide. III. Induction of Epstein-Barr virus via indirect action, as compared with TPA and teleocidin.
Oya Y; Tonomura A; Yamamoto K
Int J Cancer; 1987 Jul; 40(1):69-73. PubMed ID: 3036721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
